Alterations in brain and pituitary β-endorphin content in genetically epilepsy-prone rats

Epilepsy Research

Volumn 31, Issue 2, 1998, Pages 113-122

  Carr, J A ^a   Carpenter, A M ^a   D'Souza, M M ^a   Elmore, A R ^a   Lovering, A T ^a   Reigel, C E ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

Melanocyte stimulating hormone; Anterior lobe; Brain stem; Epilepsy; Hypothalamus; Intermediate lobe; Opioid; Radioimmunoassay

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; OPIATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPILEPSY; EPILEPTOGENESIS; HYPOPHYSIS; HYPOPHYSIS INTERMEDIATE LOBE; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ALPHA-MSH; ANIMALS; BETA-ENDORPHIN; BRAIN CHEMISTRY; EPILEPSY; PITUITARY GLAND; PITUITARY GLAND, ANTERIOR; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031877649     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00019-9     Document Type: Article

References (49)

1. Bajorek J.G., Lomax P. Modulation of spontaneous seizures in the Mongolian gerbil: effects of beta-endorphin. Peptides. 3:1982;83-86.
2. Berman E.F., Adler M.W. The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats. Neuropharmacology. 23:1984;367-371.
3. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Cain D.P., Corcoran M.E. Epileptiform effects of met-enkephalin, β-endorphin and morphine: kindling of generalized seizures and potentiation of epileptiform effects by handling. Brain Res. 338:1985;327-336.
5. 5)-enkephalinamide on α-melanocyte-stimulating hormone secretion. Regul. Pept. 47:1993;141-150.
6. Chakravarty D.N., Faingold C.L., Terry W.J., Naritoku D.K. Audiogenic seizures in genetically epilepsy prone rat induce c-fos proto-oncogene expression in the inferior colliculus and periaqueductal gray. Soc. Neurosci. Abstr. 19:1993;605.
7. Conway E.L., Maccarrone C., Jarrott B., Louis W.J. Comparison of β-endorphin immunoreactivity in hypothalamic and brainstem nuclei of normotensive and age-matched hypertensive rat strains. Neurochem. Int. 9:1986;273-279.
8. Gebhart G.F., Mitchell C.L. The effect of adrenalectomy on morphine analgesia and tolerance development in rats. Eur. J. Pharmacol. 18:1972;37-42.
9. Harrison M.B., Shumate M.D., Lothman E.W. Opioid peptide expression in models of chronic temporal lobe epilepsy. Neuroscience. 65:1995;785-795.
10. Henriksen S.J., Bloom F.E., McCoy F., Ling N., Guillemin R. β-Endorphin induces non-convulsive limbic seizures. Proc. Natl. Acad. Sci. USA. 75:1978;5221-5225.
11. Holaday J.W., Loh H.H., Li C.H. Unique behavioral effects of β-endorphin and their relationship to thermoregulation and hypothalamic function. Life Sci. 22:1978;1525-1536.
12. Holaday J.W., Tortella F.C., Meyerhoff J.L., Belenky G.L., Hitzemann R.J. Electroconvulsive shock activates endogenous opioid systems: behavioral and biochemical correlates. Ann. New York Acad. Sci. 467:1986;249-255.
13. Houser C.R., Miyashiro J.E., Swartz B.E., Walsh G.O., Rich J.R., Delgado-Escueta A.V. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci. 10:1990;267-282.
14. Jobe P.C., Picchioni A.L., Chin L. Role of norepinephrine in audiogenic seizure in the rat. J. Pharmacol. Exp. Ther. 184:1973;1-10.
15. Joseph S.A., Pilcher W.H., Knigge K. Anatomy of the corticotropin-releasing factor and opiomelanocortin systems of the brain. Fed. Proc. 44:1985;100-107.
16. Lee R.J., McCabe R.T., Wamsley J.K., Olsen R.W., Lomax P. Opioid receptor alterations in a genetic model of generalized epilepsy. Brain Res. 380:1986;76-82.
17. Lee R.J., Hong J.-S., McGinty J.F., Lomax P. Increased enkephalin and dynorphin immunoreactivity in the hippocampus of seizure sensitive Mongolian gerbils. Brain Res. 401:1987;353-358.
18. Lewis V.A., Gebhart G.F. Evaluation of the periaqueductal central gray (PAG) as a morphine-specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci. Brain Res. 124:1977;283-303.
19. Long J.B., Tortella F.C. Effects of adrenalectomy and hypophysectomy on postictal seizure protection. Brain Res. 402:1987;155-159.
20. McCown T.J., Duncan G.E., Johnson K.B., Breese G.R. Metabolic and functional mapping of the neural network subserving inferior collicular seizure generalization. Brain Res. 701:1995;117-128.
21. Millington W.R., Mueller G.P., O'Donohue T.L. Regional heterogeneity in the ratio of α-MSH:β-endorphin in rat brain. Peptides. 5:1984;841-843.
22. Mueller G.P. Attenuated pituitary β-endorphin release in estrogen-treated rats. Proc. Soc. Exp. Biol. Med. 165:1980;75-81.
23. O'Donohue T.L., Dorsa D.M. The opiomelanotropinergic neuronal and endocrine systems. Peptides. 3:1982;353-395.
24. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 59:1973;449-450.
25. Palkovits, M., Brownstein, M.J., 1988. Maps and Guide to Microdissection of the Rat Brain. Elsevier, New York.
26. Patel V.K., Abbott L.C., Rattan A.K., Tejwani G.A. Increased methionine-enkephalin levels in genetically epileptic (tg/tg) mice. Brain Res. Bull. 27:1991;849-852.
27. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
28. Pettibone D.J., Mueller G.P. Differential effects of adrenergic agents on plasma levels of immunoreactive β-endorphin and α-melanotropin in rats. Proc. Soc. Exp. Biol. Med. 176:1984;168-174.
29. Pieretti S., Di Giannuario A., Loizzo A., Sagratella S., Scotti De Carolis A., Capasso A., Sorrentino L. Dexamethasone prevents epileptiform activity induced by morphine in in vivo and in vitro experiments. J. Pharmacol. Exp. Ther. 263:1992;830-839.
30. Prezwlocka B., Stala L., Prezwlocki R. The effect of various opiate agonists on the seizure threshold in the rat. Is dynorphin an endogenous anticonvulsant? Life Sci. 33:1983;595-598.
31. Puglisi-Allegra S., Castellano C., Csanyl V., Doka A., Oliverio A. Opioid antagonism of electroshock-induced seizures. Pharmacol. Biochem. Behav. 20:1984;767-769.
32. Rees H., Ang L.-C., Shul D.D., George D.H., Begley H., McConnell T. Increase in enkephalin-like immunoreactivity in hippocampi of adults with generalized epilepsy. Brain Res. 652:1994;113-119.
33. Reigel C.E., Dailey J.W., Jobe P.C. The genetically epilepsy-prone rat: an overview of seizure prone characteristics and responsiveness to anticonvulsant drugs. Life Sci. 39:1986;763-774.
34. Reigel C.E., Jobe P.C., Dailey J.W., Stewart J.J. Responsiveness of genetically epilepsy-prone rats to intracerebroventricular morphine-induced convulsions. Life Sci. 42:1988;1743-1749.
35. Ribak C.E., Manio A.L., Navetta M.S., Gall C.M. In situ hybridization for c-fos mRNA reveals the involvement of the superior colliculus in the propagation of seizure activity in genetically epilepsy prone rats. Epilepsy Res. 26:1997;397-406.
36. Saland L.C., Carr J.A., Samora A., Benavidez S., Tejeda D. Interaction of corticotropin-releasing factor (CRF) and alpha-helical CRF on rat neurointermediate lobes: in vitro studies. Neuropeptides. 19:1991;213-221.
37. Savage D.D., Reigel C.E., Jobe P.C. The development of kindled seizures is accelerated in the genetically epilepsy-prone rat. Life Sci. 39:1986;879-886.
38. 3H]dihydromorphine binding in hippocampal formation of genetically epilepsy-prone rats. Life Sci. 43:1988;239-246.
39. Shehab S., Coffey P., Dean P., Regrave P. Regional expression of fos-like immunoreactivity following seizures induced by pentylenetetrazole and maximal electroshock. Exp. Neurol. 118:1992;261-274.
40. Smith D.J., Robertson B., Monroe P.J., Taylor D.A., Leedham J.A., Cabral J.D.Y. Opioid receptors mediating antinociception from β-endorphin and morphine in the periaqueductal gray (PAG). Neuropharmacology. 31:1992;37-50.
41. Snead O.C., Bearden L.J. The epileptogenic spectrum of opiate agonists. Neuropharmacology. 21:1982;1137-1144.
42. Tortella F.C., Long J.B. Endogenous anticonvulsant substance in rat cerebrospinal fluid after a generalized seizure. Science. 228:1985;1106-1108.
43. Tortella F.C., Long J.B. Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid. Brain Res. 456:1988;139-146.
44. Tortella F.C., Cowan A., Adler M.W. Comparison of the anticonvulsant effects of opioid peptides and etorphine in rats after i.c.v. administration. Life Sci. 10:1981;1039-1045.
45. Tortella F.C., Long J.B., Holaday J.W. Endogenous opioid systems: physiological role in self-limitation of seizures. Brain Res. 332:1985;174-178.
46. Wei E. Morphine analgesia, tolerance and physical dependence in the adrenalectomized rat. Br. J. Pharmacol. 47:1973;693-699.
47. Yeung J.C., Yaksh T.L., Rudy T.A. Concurrent mapping of brain sites for sensitivity to the direct application of morphine and focal electrical stimulation in the production of antinociception in the rat. Pain. 4:1977;23-40.
48. Yoshida M., Taniguchi Y. Projection of pro-opiomelanocortin neurons from the rat arcuate nucleus to the midbrain central gray as demonstrated by double-staining with retrograde labeling and immunohistochemistry. Arch. Histol. Cytol. 51:1988;175-183.
49. Zubieta M., Vindrola O., Talavera E., Asai M., Massarini A., Linares G. Pentylenetetrazol-induced seizures produce an increased release of ir-met-enkephalin from rat striatum in vitro. Brain Res. 360:1985;101-107.